期刊文献+

托拉塞米治疗肾性水肿疾病临床分析 被引量:7

下载PDF
导出
摘要 目的:观察托拉噻米注射液治疗肾性水肿疾病的利尿效果。方法:将88例肾病水肿患者,随机分为托拉噻米组(45例)和呋塞米组(43例),托拉塞米注射液与呋塞米注射液的用药剂量比为1∶2。2组患者均观察治疗5 d,比较治疗前后的日尿量、体重,记录用药后的不良反应。结果:治疗前后2组患者的日尿量、体重比较差异均有显著性(P<0.05)。结论:短期应用托拉噻米治疗肾性水肿疾病的利尿效果显著,不良反应少于呋塞米。
出处 《河南大学学报(医学版)》 CAS 2007年第3期50-51,共2页 Journal of Henan University:Medical Science
  • 相关文献

参考文献5

二级参考文献31

  • 1[1][1] Blose JS,Adams KF Jr,Patterson JH. Torsemide:a pyridine-sulfonylurea loop diuretic[J]. Ann Pharmacother, 1995,29(4): 396 - 402.
  • 2[2]Brater DC. Clinical pharmacology of loop diuretics [J]. Drugs,1991,41 (Suppl 3) :S14 - S22.
  • 3[3]Frieder HA,Buckley MM-T. Torasemide-a review of its pharmacology, properties and therapeutic potential [J]. Drugs, 1991,41(1) :S81 - S103.
  • 4[4]Bart WH,Smith HL,Karnes HT,et al.Torasemide dose proportionality of pharmacokinetics and pharmacodynamics [J]. Prog Pharmacol Clin Pharmacol, 1990,8: 29 - 37.
  • 5[5]Fowler SF, Murray KM. Torsemide: A new loop diruetic [J].Am J Health-Syst Pharm, 1995,52(15): 1771 - 1780.
  • 6[6]Knauf H,Spahn H,Mutschler E. The loop diuretic torasemide in chronic renal failure: pharmacokinetics and pharmacodynamics [J]. Drugs, 1991,41 (Suppl 3) :S23 - S34.
  • 7[7]Kido H,Ohtaki Y. Torasemide (LUPRAC) :a review of its pharmacological and clinical profile[J]. Nippon Yakeurigaku Zasshi,2001,118(2):97- 105.
  • 8[8]Kruck F. Acute and long term effects of loop diuretics in heart failure[J]. Drugs, 1991,41 (Suppl 3): S60 - S68.
  • 9[9]Barr WH,Smith HL,Karnes HT,et al. Comparison of bioavailability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers[J]. Prog Pharmacol Clin Pharmmol, 1990 ;8:15 - 28.
  • 10[10]Schwartz S,Brater DC,Pound D,et al. Bioavailability,pharmacokinetics and pharmacodynamics of torasemide in patients with cirrhosis[J]. Clin Pharmacol Ther, 1993,54(1): 90 - 97.

共引文献81

同被引文献46

  • 1邹建洲,滕杰,丁小强,吉俊,王吉耀,李志善,陈楠,袁耀宗,戚文航,顾勇,卢洪洲,蒋文斌,范维琥.托拉塞米注射液治疗水肿性疾病安全性和利尿效果研究[J].中华肾脏病杂志,2005,21(2):95-97. 被引量:38
  • 2侯桂梅,张晓.糖尿病并发低血钾48例临床分析[J].河南职工医学院学报,2005,17(2):93-94. 被引量:4
  • 3潘阳彬,江德文,李桂芬,陈怡.托拉塞米治疗肾性水肿疗效观察[J].中国误诊学杂志,2007,7(5):988-988. 被引量:2
  • 4刘喜红,易著文,陈丹,曾雪琪,黄丹琳,姜奕.肾病综合征水肿治疗效果的循证医学证据[J].中国当代儿科杂志,2007,9(2):139-143. 被引量:17
  • 5易著文,刘喜红.肾病综合征水肿的治疗[J].中国实用儿科杂志,2007,22(6):403-406. 被引量:5
  • 6Vargas Hein O, Staegemann M, Wagner D, von Heymann C, Mar- tin M, Morgera S, et al. Torsemide versus furosemide after continu- ous renal replacement therapy due to acute renal failure in cardiac surgery patients[J]. Ren Fail, 2005, 27(4) : 385-392.
  • 7De Haes A, Proost JH, De Baets MH, Stassen MH, Houwertjes MC, Wierda JM. Pharmacokinetic-pharmacodynamic modeling of rocuroninm in case of a decreased number of acetylcholine recep- tors: a study in myasthenic pigs [ J ]. Anesthesiology, 2003, 98 ( 1 ) : 133-142.
  • 8Van der Vorst MM, Kist JE, van der Heijden A J, Burggraaf J. Di- uretics in pediatrics: current knowledge and future prospects[ J]. Pediatr Drugs, 2006, 8 (4) : 245-264.
  • 9Doucet A, Favre G, Deschenes G. Molecular mechanism of edema formation in nephritic syndrome : theraeutic implications [ J ]. Pedi- atr Nephrol, 2007, 22(12) : 1983-1990.
  • 10Blose JS, Adams KF Jr, Patterson JH. Torsemide: a pyridine-sul- fonylurea loop diuretic [ J ]. Ann Pharmacother, 1995, 29 (4) : 396-402.

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部